1.	Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer Phase: Phase IV Type: Diagnostic Status: Closed Age: 25 and over Sponsor: Other Protocol IDs: PEM-06-01, NIH Grant: 5 R44 CA103102-05, NCT00484614
2.	Phase II/III Diagnostic Study of Whole Body Fludeoxyglucose F 18 Positron Emission Tomography to Measure the Response to Induction Chemotherapy of Potentially Resectable Lung and Esophageal Carcinomas (Summary Last Modified 12/2001) Phase: Phase III, Phase II Type: Diagnostic Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-96079, NCI-G97-1334, NCT00002930
3.	Phase II/III Diagnostic Study of C11-Methionine and 2-F18-Fluoro-2-deoxy-D-Glucose (FDG) Positron Emission Tomography (PET) Imaging in Patients With Progressive Prostate Cancer Phase: Phase III, Phase II Type: Diagnostic Status: Closed Age: Not specified Sponsor: NCI Protocol IDs: MSKCC-97007, NCI-G97-1232, NCT00002981
4.	Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer Phase: Phase III, Phase II Type: Diagnostic Status: Completed Age: 15 and over Sponsor: Other Protocol IDs: SP-11-0035/DX-FDG-001/21221, NCT00123760
5.	Phase II/III Study of Multimodality Breast Imaging Comprising Digital Mammography, Ultrasound, MRI, and Positron Emission Tomography in Women With Newly Diagnosed Breast Cancer Phase: Phase III, Phase II Type: Diagnostic Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UPCC-12199, UPCC-414500, NCT00194337
6.	A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation Phase: Phase III, Phase II Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: FLT101, NCT00847509
7.	Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases Phase: Phase III Type: Diagnostic, Treatment Status: Completed Age: 18 to 75 Sponsor: Other Protocol IDs: POLEM (ZonMW DO 945-11017), (ZonMW DO 945-11017), NCT00119899
8.	Usefulness of FDG-PET for Advanced Cervical Cancer Phase: Phase III Type: Diagnostic Status: Closed Age: no age specified Sponsor: Other Protocol IDs: CTRP024, NSC 92-2314-B-182A-084, NCT00146458
9.	Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial) Phase: Phase III Type: Diagnostic Status: Completed Age: 18 to 80 Sponsor: Other Protocol IDs: CTA-Control-088421, NCT00147472
10.	PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) Phase: Phase III Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CTA-Control-092493, NCT00201942
11.	PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer Phase: Phase III Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: P020907, NCT00236275
12.	Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV Phase: Phase III Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: NLG PET Study, NCT00286832
13.	A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OSI3926g, ML20773, NCT00453362
14.	Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: Over 18 Sponsor: Other Protocol IDs: CDR0000553410, EORTC-24051, EUDRACT-2006-002667-33, GSK-EORTC-24051, NCT00498953
15.	Phase I/II Study of Everolimus, Temozolomide, and 3D-Conformal Radiotherapy or Intensity-Modulated Radiotherapy Followed by Adjuvant Temozolomide With or Without Everolimus in Patients With Newly Diagnosed Glioblastoma Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N057K, N057K, NCT00553150
16.	Phase I/II Study of Cediranib, Temozolomide, and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MGH-07-344, 07-344, PHS 398/2590, 8030, NCT00662506
17.	Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy and Positron Emission Tomography (PET) in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum Carcinoembryonic Antigen (CEA) Levels in the Absence of Imageable Disease by Conventional Modalities Phase: Phase II Type: Diagnostic Status: Completed Age: Over 18 Sponsor: NCI Protocol IDs: NCI-97-C-0068
18.	PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma Phase: Phase II Type: Diagnostic Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067385, MSKCC-99004, NCI-G99-1619, NCT00004152
19.	Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas Phase: Phase II Type: Treatment Status: Closed Age: 4 to 35 Sponsor: NCI Protocol IDs: 020259, 02-C-0259, NCI-02-C-0259, NCT00047372, NCT00043979
20.	Phase II Study of Neoadjuvant Irinotecan and Cisplatin Followed By Surgical Resection in Patients With Locally Advanced Resectable Adenocarcinoma of the Stomach or Gastroesophageal Junction Phase: Phase II Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-03032, NCI-5917, NCT00062374, 5917
21.	Phase II Study of Fludeoxyglucose F18 Positron Emission Tomography for Pre- and Post-treatment Assessment in Patients With Locally Advanced Non-Small Cell Lung Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: ACRIN-6668, RTOG-0235, NCT00083083
22.	FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma Phase: Phase II Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SG015-0005, NCT00086333
23.	Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Phase: Phase II Type: Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 6228, P30CA015704, UWCC-6228, UWCC-UW-6228, UW-04033, LILY-UW-04033, CDR0000441239, NCT00227539
24.	Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer Phase: Phase II Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: LU-11-0044/DX-FDG-007/21389, NCT00123747
25.	Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence Phase: Phase II Type: Diagnostic Status: Completed Age: 15 and over Sponsor: Other Protocol IDs: SP-14-0038/DX-FDG-003/21386, NCT00123773